Which has grown faster, ATRC or RXRX?

Over the past five years, RXRX grew revenue faster — ATRC at a 18.57% CAGR versus RXRX at 45.50%.

Is ATRC or RXRX more profitable?

ATRC runs the higher net margin — ATRC at 1.85% versus RXRX at -945.92%.

How have ATRC and RXRX total returns compared?

Over the past 5 years, ATRC delivered -4.06% and RXRX delivered -25.86% annualized total return. Past performance doesn't predict future results.

AtriCure, Inc. (ATRC) vs Recursion Pharmaceuticals, Inc. (RXRX)

A side-by-side comparison of AtriCure, Inc. and Recursion Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ATRC

AtriCure, Inc.

$2.83B

$55.59HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

RXRX

Recursion Pharmaceuticals, Inc.

$2.43B

$4.63HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

Total return — ATRC vs RXRX

growth of $100 · dividends reinvested · last 5y

ATRC -15.0% (-3.2%/yr)RXRX -73.4% (-23.3%/yr)ATRC compounded faster over this window

ATRC RXRX

ATRC vs RXRX: by the numbers

•ATRC is the larger company ($2.83B vs $2.43B market cap).
•ATRC is profitable (1.85% net margin) while RXRX runs a net loss (-945.92%).
•RXRX grew revenue faster over the past five years (45.50% vs 18.57% CAGR).

Metrics side by side

Valuation

Metric	ATRC	RXRX
P/E ratio	261.97	N/A
P/S ratio	4.96	44.29
P/B ratio	5.48	2.65
EV / EBITDA	78.60	N/A
FCF yield	1.81%	N/A

Profitability

Metric	ATRC	RXRX
Gross margin	76.16%	-61.96%
Operating margin	2.44%	-867.87%
Net margin	1.85%	-945.92%
ROE	2.04%	-56.71%
ROIC	2.04%	-49.78%

Growth (annualized)

Metric	ATRC	RXRX
Revenue CAGR (5Y)	18.57%	45.50%
Total return CAGR (5Y)	-4.06%	-25.86%

Frequently asked

Which has grown faster, ATRC or RXRX?: Over the past five years, RXRX grew revenue faster — ATRC at a 18.57% CAGR versus RXRX at 45.50%.
Is ATRC or RXRX more profitable?: ATRC runs the higher net margin — ATRC at 1.85% versus RXRX at -945.92%.
How have ATRC and RXRX total returns compared?: Over the past 5 years, ATRC delivered -4.06% and RXRX delivered -25.86% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ATRC analysis Full RXRX analysis Interactive comparison tool

Dig into the metrics

AtriCure P/E ratio AtriCure ROE Recursion Pharmaceuticals ROE AtriCure operating margin Recursion Pharmaceuticals operating margin AtriCure revenue growth Recursion Pharmaceuticals revenue growth AtriCure free cash flow Recursion Pharmaceuticals free cash flow

AtriCure & Recursion Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.